ロード中...
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
Immune checkpoint blockade therapy is a powerful treatment strategy for many cancer types. Many patients will have limited responses to monotherapy targeted to a single immune checkpoint. Both inhibitory and stimulatory immune checkpoints continue to be discovered. Additionally, many receptors previ...
保存先:
| 出版年: | Int J Mol Sci |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6337574/ https://ncbi.nlm.nih.gov/pubmed/30621125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20010158 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|